These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
90 related articles for article (PubMed ID: 5289458)
1. [Lung changes under busulfan therapy in a case of chronic myelosis]. Kolarz G; Pietsehmann H; Regele H Zentralbl Allg Pathol; 1970; 113(5):539-44. PubMed ID: 5289458 [No Abstract] [Full Text] [Related]
2. Pulmonary lesions associated with busulfan therapy of chronic myelogenous leukemia. Kirschner RH; Esterly JR Cancer; 1971 May; 27(5):1074-80. PubMed ID: 5281244 [No Abstract] [Full Text] [Related]
3. [Liver damage during use of busulfan]. Adang RP; Breed WP Ned Tijdschr Geneeskd; 1989 Jul; 133(30):1515-8. PubMed ID: 2797253 [TBL] [Abstract][Full Text] [Related]
13. Busulphan and the lungs. Absence of lung function disturbance in patients treated with busulphan. Comhaire F; Van Hove W; Van Ganse W; Van der Straeten M Scand J Respir Dis; 1972; 53(5):265-73. PubMed ID: 4508954 [No Abstract] [Full Text] [Related]
14. [Successful treatment of primary myelofibrosis by busulfan pulse therapy: report of a case]. Uemura Y; Iwahara Y; Kataoka R; Muneishi H; Miyoshi I Rinsho Ketsueki; 1990 Sep; 31(9):1553-6. PubMed ID: 2246832 [TBL] [Abstract][Full Text] [Related]
15. Myelofibrosis, diffuse alveolar hemorrhage and radiation treatment. Richters ML Am J Hematol; 2013 Oct; 88(10):922. PubMed ID: 23798379 [No Abstract] [Full Text] [Related]
16. Myelofibrosis: response to busulfan after hydroxyurea failure. Naqvi T; Baumann MA Int J Clin Pract; 2002 May; 56(4):312-3. PubMed ID: 12074218 [TBL] [Abstract][Full Text] [Related]